Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06188689 · ClinicalTrials.gov registry record · NA
Evaluation of A Clinical Diagnostic Test for CRDS
A NA study of Calcium Release Deficiency Syndrome (CRDS), sponsored by Population Health Research Institute.
- Recruiting
- Registry status
- NA
- Development phase
- 400
- Enrollment target
- 18
- Study locations
NCT06188689 is a NA study of Calcium Release Deficiency Syndrome (CRDS) that is actively recruiting participants, run by Population Health Research Institute. The registered enrollment target is 400 participants. The trial reports 18 study locations across 11 states.
The verdict
NCT06188689, a NA study of Calcium Release Deficiency Syndrome (CRDS), is actively recruiting participants, sponsored by Population Health Research Institute.
- RECRUITING
- Registry status
- NA
- Development phase
- 400 participants
- Enrollment target
- 18
- Study locations
Study Summary
Calcium Release Deficiency Syndrome (CRDS) is a novel inherited arrhythmia syndrome secondary to RyR2 loss-of-function that confers a risk of sudden cardiac death. Diagnosis of CRDS presently requires cellular-based in vitro confirmation that an RyR2 variant causes loss-of-function. We hypothesize that CRDS can be diagnosed clinically through evaluation of the repolarization response to brief tachycardia, mediated by cardiac pacing, and a subsequent pause.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Pacing
Study Locations (18)
Ontario
- Hamilton General Hospital - Hamilton
- London Health Sciences Centre - University Hospital - London
- Ottawa Heart Institute - Ottawa
- Toronto General Hospital - Toronto
Other
- Universitair Ziekenhuis Brussel - Brussels
- Aarhus University Hospital - Aarhus
- Shaare Zedek Medical Center - Jerusalem
British Columbia
- Children's & Women's Health Centre of British Columbia - Vancouver
- The University of British Columbia - Vancouver
Quebec
- Montréal Heart Institute - Montreal
- Institut Universitaire de Cardiologie et de Pneumologie de Québec-Université Laval - Québec
California
- University of California - San Francisco
Minnesota
- Mayo Clinic - Rochester
Washington
- University of Washington - Seattle
Antwerp
- Antwerp University Hospital - Edegem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2023-02-02 |
| Est. Completion | 2026-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06188689
The ClinicalTrials.gov registry entry for NCT06188689 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Population Health Research Institute, which has 21 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Calcium Release Deficiency Syndrome (CRDS) appearing as the primary indexed condition, and to 1 intervention - of which Pacing is the first listed.
NCT06188689 reports 18 study locations spanning 11 distinct geographic areas - top geographies include Ontario, Other, British Columbia.
Frequently Asked Questions
What is clinical trial NCT06188689 about?
NCT06188689 is a clinical study titled "Evaluation of A Clinical Diagnostic Test for CRDS". Calcium Release Deficiency Syndrome (CRDS) is a novel inherited arrhythmia syndrome secondary to RyR2 loss-of-function that confers a risk of sudden cardiac death. Diagnosis of CRDS presently requires cellular-based in vitro confirmation that an RyR2 variant causes loss-of-function. We hypothesize t...
What is the current status of trial NCT06188689?
This trial is currently recruiting. It is a NA study. The enrollment target is 400 participants. The study started on 2023-02-02. Estimated completion is 2026-03.
What conditions does trial NCT06188689 study?
This clinical trial studies the following conditions: Calcium Release Deficiency Syndrome (CRDS).
What interventions are being tested in trial NCT06188689?
The interventions under investigation include: Pacing (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06188689?
This trial is sponsored by Population Health Research Institute, which has 21 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06188689 being conducted?
This trial has 18 study locations across California, Minnesota, Washington, Antwerp, Alberta. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.